COVID-19 pandemic research opportunities in India
The primary goal has been to maintain a balance between maintaining quality of life among waitlist patients and the risk of acquiring or transmitting COVID-19 during transplant. SOT in recovered donors and recipients is feasible and safe, with equivalent outcomes and no changes in immunosuppression compared with routine practice. SOT recipients do not have many differences in presentation of SARSCoV-2 compared with the general population, although mortality and morbidity rates in SOT recipients are higher. Indian transplant societies have done a tremendous job by formulating and amending guidelines that helped to pave the path for safe practices across Indian transplant centers.
MAT-IN-2201268 – 1.0 – 5/2022